Biomarin Pharmaceutical reported $1.08B in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acceleron Pharma XLRN:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 0M 236.9M
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Bayer BAYN:GR € 40372M 2493M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Insmed INSM:US $ 564.02M 186.91M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
IONIS PHARMACEUT IONS:US $ 1310.54M 370.12M
Moderna Inc MRNA:US 487M 304M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Ptc Therapeutics PTCT:US $ 1161.83M 15.06M
Puma Biotechnology PBYI:US $ 100.14M 0.93M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 34.25M 0.22M